Based on the above data, Anti-EGFR-CILs demonstrated possessed more specificity to actively target GBC compared with other control groups42–44, gathering at the tumour tissue surface to transfect greater amounts of miR-135a plasmid into the tumour tissue45–47. This evidence concerns the gene EGFR and neoplasm.